NCT06276491 2026-03-17
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Phase 1 Recruiting
Clinical Trials
13 trialsNCT07463508 2026-03-11
TG-BIL
University Hospital, Clermont-Ferrand
Phase NA Recruiting
NCT05946993 2026-03-04
LIAM Mc
University College Cork
Phase NA Active not recruiting
NCT07406087 2026-02-25
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
Phase NA Not yet recruiting
NCT06515613 2026-02-20
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Context Therapeutics Inc.
Phase 1 Recruiting
NCT06593665 2026-02-13
RPLND
Indiana University
Phase 3 Recruiting
NCT07407582 2026-02-12
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
Phase 1/2 Not yet recruiting
NCT04503278 2026-02-11
A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
BioNTech SE
Phase 1 Recruiting
NCT07228637 2026-02-09
PERSIST
Indiana University
Phase NA Active not recruiting
NCT04459273 2026-02-05
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT06828185 2026-02-04
PRESERVE
Loma Linda University
Phase NA Recruiting
NCT07218913 2026-01-26
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
Phase 1 Recruiting
NCT03937843 2026-01-20
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
Swiss Cancer Institute
Phase 2 Active not recruiting